Navigation Links
Concerns Rise About New Phentermine Drug According to Houston Chronicle Report

Vienna, VA (PRWEB) August 28, 2013

While patients may see weight loss using new prescription drug options that contain phentermine, some risks may simply outweigh the benefits for many patients, according to a new article entitled, “Diet pills stir debate as more enter market,” from the Houston Chronicle published on August 13, 2013.

Phentermine was part of the popular diet combination pill known as fen-phen, which the article states was removed from the market in 1997 because the “fen” half of the combination, fenfluramine, was known to cause heart damage. Phentermine remained available, but was only approved for patient short-term usage due to possible side effects.

The FDA has now approved Qsymia, another combination drug that contains phentermine, though it initially rejected the drug as being unsafe last year. The article states that it is unclear what caused this about-face, though this new phentermine combination drug has been approved on the basis that long-term trials will have to be performed to determine if it is safe. Dr. John Swartzberg, a clinical professor from UC Berkeley, states in the article that he would be leery to prescribe any diet medication, including the new phentermine combo drug, to his patients that hadn't passed a “three- to five-year test” of proving that it doesn't cause any side effects in three to five years of widespread usage. It will be available to the public while these trials are being performed.

The Houston Chronicle also mentions that Consumer Reports, a trusted consumer reviewing publication, has recommended that individuals not take this new phentermine combination drug due to the risks, which include possible birth defects. Despite the fact that there are more than 78 million obese adults in the US, according to the article, concerns expressed by publications like Consumer Reports and fears of side effects lead to extremely poor sales of Qsymia, the drug containing phentermine.

The main side effects of phentermine, according to a patient who shared her story for the article, are appetite suppression and an increase in energy. These same results can be achieved with phenylethylamine HCL, the main ingredient in PhenObestin 37.5 from This pharmaceutical grade supplement is available without a prescription, and unlike phentermine which has not been determined safe for long term usage, PhenObestin 37.5 can be used until an individual reaches their goal or whenever one needs extra energy or help with appetite suppression. This safe alternative to phentermine, and adipex, is available today by calling 1-800-935-6312 or visiting

Based in the suburbs of Maryland, offers effective weight loss products while providing customers with a unique shopping experience. Their offerings strive to assist customers to lose weight as effortlessly as possible. With a commitment to quality and client satisfaction, has helped countless individuals tackle weight related problems.

Operating as one-of-a-kind online pharmacy, their customers come from every corner of the world. Celebrating a proud legacy of a customer-base that continues to grow, works towards ensuring health for every single client. Dealing in supplements, muscle building vitamins and a wide array of weight loss products, they never fail to meet and exceed expectations.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Concerns about MRSA for expectant mothers may be unfounded
2. Study answers Medicare concerns about paying for CT colonography
3. University of Louisville study dispels concerns about drive-thru flu clinics
4. New survey shows patient concerns and misinformation impede treatment of menopausal women
5. Climate concerns
6. Debt and income concerns deter medical students from primary care careers
7. Hair Concerns May Discourage Exercise for Some Black Women
8. US Drug Watchdog Now Urges All Recipients Of A All Metal Hip Implant to Get A Blood Test Out of New Concerns About Side Effects and They Name Law Firms To Help Victims
9. Online message boards provide outlets for mothers concerns, MU researcher says
10. Hog Ties, Duct Tape, and Airlines: Lawyers at Console & Hollawell Discuss Liability Concerns over Restraining Passengers Mid-Flight
11. Increasing concerns surrounding surrogacy
Post Your Comments:
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
Breaking Medicine Technology: